Aldosterone-Renin Ratio (ARR) Test
The aldosterone-renin ratio compares aldosterone with renin and is the principal screening approach for primary aldosteronism, an important and treatable cause of hypertension. Accurate testing depends heavily on potassium level, sodium intake, posture, time of day and medications.
Primary aldosteronism screening
Complete Renin-Angiotensin-Aldosterone Profile (PAC + Direct Renin / PRA + Calculated ARR)
Paired EDTA Plasma (for Renin) and Serum (for Aldosterone) (4 mL total) (2 mL)
24–48 Hours
Preparation & Fasting Guidelines
When Should You Get Tested?
Detailed Clinical Overview
The Renin-Angiotensin-Aldosterone System (RAAS) is the hormonal cascade that governs systemic arterial blood pressure, renal sodium reabsorption, extracellular fluid volume, and potassium excretion. Renin, synthesised by renal juxtaglomerular cells, cleaves angiotensinogen to produce angiotensin I, subsequently converted to angiotensin II, which potently stimulates adrenal zona glomerulosa secretion of Aldosterone.
Primary Aldosteronism (Conn syndrome) is caused by autonomous overproduction of aldosterone independent of the RAAS—most commonly due to a solitary aldosterone-producing adrenal adenoma (APA) or bilateral adrenal hyperplasia (BAH). It is now recognised as the single most common cause of secondary endocrine hypertension, affecting 5–10% of all hypertensive patients and over 20% of patients with treatment-resistant hypertension.
Autonomous hyperaldosteronism suppresses renal renin secretion through volume expansion. Calculating the Aldosterone-Renin Ratio (ARR)—dividing Plasma Aldosterone Concentration (PAC) by Direct Renin Concentration (DRC) or Plasma Renin Activity (PRA)—provides the primary screening test recommended by international endocrine guidelines.
Clinical Significance
Screening and detecting primary aldosteronism is critical because hyperaldosteronism causes severe, disproportionate cardiovascular, renal, and cerebrovascular end-organ damage (fibrosis, left ventricular hypertrophy, stroke, albuminuria). Unilateral adenomas can be cured completely with laparoscopic adrenalectomy, while bilateral hyperplasia is targeted effectively with mineralocorticoid receptor antagonists (spironolactone/eplerenone).
Diagnostic Limitations & Interferences
- Multiple antihypertensive medications profoundly alter renin and aldosterone dynamics: mineralocorticoid receptor antagonists (spironolactone, eplerenone) must be stopped for 4–6 weeks; beta-blockers suppress renin (false-positive ARR); ACE inhibitors and ARBs elevate renin (false-negative ARR). Medication adjustments must be strictly doctor-supervised.
- Hypokalaemia directly suppresses aldosterone synthesis, creating false-negative ARR; hypokalaemia MUST be corrected with potassium supplementation prior to drawing blood.
- An elevated ARR caused by extremely low renin with low or normal aldosterone is not diagnostic; a minimal Plasma Aldosterone threshold (typically > 10–15 ng/dL) is required.
- ARR is a screening test; positive screens require confirmatory suppression testing (saline infusion or fludrocortisone test) before invasive subtype adrenal venous sampling (AVS).
Why Get Tested at QXL Diagnostics?
Reference Ranges — Aldosterone-Renin Ratio (ARR) Test
NABL-validated intervals · Adults · values may vary by age & sex
| Parameter / Group | Range | Unit | Status |
|---|---|---|---|
| Plasma Aldosterone Concentration (PAC - Seated)Normal seated morning range | 3.0 – 35.3 | ng/dL | Normal |
| Direct Renin Concentration (DRC - Seated)Normal seated morning range | 4.4 – 46.1 | µIU/mL | Normal |
| Aldosterone-Renin Ratio (ARR Screen Negative)Primary aldosteronism unlikely | < 2.0 | ratio (ng/dL per µIU/mL) | Normal |
| Aldosterone-Renin Ratio (ARR Screen Positive)Suggestive of Primary Aldosteronism if PAC > 10–15 ng/dL | ≥ 2.0 – 3.7 | ratio (ng/dL per µIU/mL) | Abnormal |
⚕️ Reference ranges are population-based guidelines. Results must be interpreted in clinical context by a qualified physician. Always consult your doctor before making healthcare decisions.
Frequently Asked Questions
Q: Why test for primary aldosteronism?
A: Primary aldosteronism is a treatable and often curable cause of high blood pressure that causes disproportionate heart, kidney, and stroke damage if left undiagnosed.
Q: Can blood-pressure medicines affect ARR?
A: Yes, significantly. Diuretics, spironolactone, beta-blockers, ACE inhibitors, and ARBs alter renin and aldosterone levels. Your doctor may temporarily transition you to verapamil or alpha-blockers prior to testing.
Q: Why is potassium checked?
A: Low potassium suppresses the adrenal gland's ability to release aldosterone, which can cause a false-negative screen. Potassium levels must be normal before drawing blood.
Q: Should I reduce salt before the test?
A: No. You should maintain normal, unrestricted dietary salt intake. Restricting sodium stimulates renin and alters the ratio.
Q: Does a high ARR prove primary aldosteronism?
A: No. A high ratio is a positive screen that identifies patients who require confirmatory suppression testing (like intravenous saline loading) to establish definitive autonomy.
Q: Is the test done lying down or sitting?
A: Guidelines recommend collecting the sample in the morning after being up and active for at least 2 hours, followed by sitting quietly for 5 to 15 minutes prior to the blood draw.
When Should a Patient Seek Urgent Medical Care?
Urgent care is determined by symptoms, not by waiting for a laboratory report. Seek immediate emergency medical care for severe hypertensive crisis (blood pressure > 180/120 mmHg), acute severe headache, vision changes, chest pain, or shortness of breath. A laboratory test page must never delay emergency care.
⚠️ Urgent care is determined by symptoms, not by waiting for a laboratory report. A laboratory test page must never delay emergency care.
Evidence Base & Clinical Guidelines
- •Tietz Clinical Guide to Laboratory Tests, 4th ed. Alan H. B. Wu, PhD, DABCC, FACB. W.B. Saunders/Elsevier, 2006.
- •Endocrine Society Clinical Practice Guideline: The Management of Primary Aldosteronism (J Clin Endocrinol Metab 2016).
Global Medical Disclaimer
This page is for patient education and search/AI information retrieval. It does not diagnose disease, replace a clinical examination, or override the reference interval and interpretive comment on the patient's own laboratory report. Reference intervals, decision limits, specimen requirements and assay interferences can differ by method, age, sex, pregnancy status, clinical setting and laboratory platform. Results must be interpreted with symptoms, examination, medicines, imaging and other investigations.
Related Tests at QXL Diagnostics
Includes free doorstep home sample collection
Book Home Collection →Or call: +91 9964 639 639MD (Medical Biochemistry), Consultant Biochemist - 25 years of experience · Primary aldosteronism screening
Up to 10% of all hypertensive patients suffer from primary aldosteronism, yet fewer than 1% are ever screened. When high blood pressure is accompanied by low potassium or resistance to standard drugs, calculating the ARR is the crucial diagnostic step that can turn lifelong drug dependence into a curable condition.
Clinically reviewed · November 2026 · QXL Diagnostics NABL Lab
NABL Quality Guarantees
NABL Accredited (MC-6849)
ISO 15189:2022 — Medical laboratories — Requirements for quality and competence quality compliance
Same-Day Digital Reports
Delivered straight to WhatsApp & Email
Free Doorstep Collection
Sterile vacuum containers & cold-chain kits
